Surmodics | SRDX - Market Capitalization


Surmodics reported $393.5M in Market Capitalization this April of 2024, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Abbott USD 217.86B 15.25B Dec/2025
Align Technology USD 12.04B 838M Feb/2026
Anika Therapeutics USD 379M 166M Jun/2025
Arrowhead Research USD 8.04B 973M Feb/2026
Baxter International USD 11.7B 3.84B Sep/2025
Boston Scientific USD 110.32B 31.04B Feb/2026
EDAP TMS EUR 62M 11M Jun/2025
Edwards Lifesciences USD 45.47B 4B Feb/2026
Haemonetics USD 3.3B 456M Feb/2026
Heron Therapeutics USD 145M 6M Sep/2023
J&J USD 500.24B 67.44B Dec/2025
Merit Medical Systems USD 4.93B 591M Sep/2025
Nektar Therapeutics USD 113M 4M Sep/2023
Option Care Health USD 4.5B 815M Sep/2025
Stryker USD 134.41B 6.92B Dec/2025
Surmodics USD 418M 99M Mar/2024
Trinity Biotech USD 6M 7M Feb/2026